• Human Longevity Acquires Cypher Genomics, Genomics Interpretation Software

    Bio-IT World | Human Longevity this morning announced that it has acquired Cypher Genomics for an undisclosed amount. Cypher has 14 employees who will join HLI including Cypher CEO and Co-founder, Ashley Van Zeeland, Ph.D., who is now the head of HLI's Pediatric Business.

    Nov 30, 2015
  • Microbiome Startup uBiome Will Sequence Poop for the CDC

    Wired | uBiome has announced a partnership with the Centers for Disease Control and Prevention to develop a standardized way of measuring disruptions and changes to the human microbiome.

    Nov 30, 2015
  • Systematic CRISPR Knockouts in Cancer Cell Lines

    The Atlantic | CRISPR-Cas9 experiments are revealing which human genes are essential, and which matter specifically to cancer cells.

    Nov 30, 2015
  • Quanterix Upgrades Simoa Instruments, Preparing for 2016 IPO

    Diagnostics World | Quanterix, the Lexington, Mass.-based creator of a high-throughput protein analysis instrument, is overhauling its hardware and software as it prepares for a more commercial stage in its development.

    Nov 25, 2015
  • Complete Genomics Loses Staff, Delays Revolocity as BGI Seeks Support for BGISEQ-500

    Bio-IT World News Brief | Complete Genomics of Mountain View, Calif., is undergoing a big shakeup under the direction of its Shenzhen-based owner BGI, reorganizing as a research site developing assays for the BGISEQ-500 and cutting short the launch of its Revolocity clinical sequencing system.

    Nov 24, 2015
  • Mosquito Gene Drive Appears Successful in the Lab

    STAT | Scientists have used the CRISPR-Cas9 genome-editing tool to create mosquitoes that block the malaria parasite instead of transmitting it - and rapidly spread their modified DNA to nearly all their descendants.

    Nov 23, 2015
  • Thermo Fisher Prepares for NGS Cancer Testing with Pharma Partners

    Bio-IT World | Thermo Fisher Scientific announced this week that it will be creating a next-generation sequencing test as a companion diagnostic in cases of non-small cell lung cancer, partnering with Novartis and Pfizer.

    Nov 20, 2015
  • Oxford Nanopore's Software Side

    Bio-IT World | Oxford Nanopore, creator of the handheld MinION DNA sequencer, recently revealed its first user-facing tool for genetic interpretation, a species identification workflow called What's in my Pot? The tool, designed by Oxford's software spinout Metrichor, hints at the company's ambitions to bring DNA analysis to a much wider audience, as the MinION broadens notions of who can perform sequencing and where.

    Nov 19, 2015
  • How Genetics Defines, and Redefines, Biological Sex

    Nature News | The idea of two sexes, divided neatly by X and Y chromosomes, is simplistic. Biologists are now finding a fascinating number and variety of ways genetics can defy the binary.

    Nov 19, 2015
  • Deep Genomics Closes Seed Round of $3.7m

    Bio-IT World | Deep Genomics this morning announced the closing of $3.7 million in seed financing. Funding was led by True Ventures of the Bay Area with participation from Bloomberg Beta and other global angel investors.

    Nov 18, 2015
  • Former Biogen R&D Chief Emerges at $80M Startup Pursuing Cancer Alzheimers

    Forbes | Doug Williams left one of biotechnology's biggest jobs, at Biogen, in July. Now we know why. Williams is now the founding CEO of Codiak Biosciences, a Cambridge, Mass.-based startup. The little company is announcing today it has raised $80 million in committed venture capital spread over two installments.

    Nov 17, 2015